搜索临床试验以:Filanesib, KSP (Eg5) inhibitor; intravenous
总计1888个结果
-
Affiliated Cancer Hospital & Institute of Guangzhou...招聘中
-
Hospira, now a wholly owned subsidiary of Pfizer完全的
-
University Hospital Inselspital, BerneGE Healthcare完全的
-
Sisli Hamidiye Etfal Training and Research Hospital尚未招聘
-
University of Southern CaliforniaNational Cancer Institute (NCI)招聘中真性红细胞增多症 | 原发性血小板增多症 | 骨髓纤维化 | 骨髓增生异常综合症 | 意义未明的克隆性血细胞减少症美国
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)完全的疼痛 | 淋巴瘤 | 骨髓增生异常综合征 | 白血病 | 慢性骨髓增生性疾病 | 未明确的成人实体瘤,特定方案 | 神经毒性 | 多发性骨髓瘤和浆细胞肿瘤 | 淋巴增生性疾病 | 骨髓增生异常/骨髓增生性肿瘤美国
-
University of OxfordLondon School of Hygiene and Tropical Medicine; Medical Research Council; Wellcome Trust; Department... 和其他合作者完全的
-
Regeneron PharmaceuticalsSanofi完全的
-
University of Alabama at BirminghamNational Center for Research Resources (NCRR)完全的
-
Southern California Institute for Research and...National Institute of Mental Health (NIMH); University of California, Irvine未知
-
AbbVieBoehringer Ingelheim完全的
-
University Hospital Southampton NHS Foundation...Janssen-Cilag Ltd.完全的
-
Seagen Inc.Millennium Pharmaceuticals, Inc.完全的
-
University of TurkuOrion Corporation, Orion Pharma完全的
-
Daiichi Sankyo, Inc.Medpace, Inc.完全的
-
The Cleveland ClinicGlaxoSmithKline; Currax Pharmaceuticals完全的